EEM vs IBB
iShares MSCI Emerging Markets ETF vs iShares Biotechnology ETF
- • IBB has the lower expense ratio at 0.44% vs 0.72% for EEM.
- • EEM pays a higher dividend yield (1.91%).
Side-by-side metrics
| Metric | EEM | IBB |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.72% | 0.44% |
Dividend yield Trailing 12-month yield. | 1.91% | 0.23% |
AUM Assets under management — bigger funds are typically more liquid. | $28.10B | $7.95B |
YTD return | 23.36% | 3.10% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.00 | 0.74 |
P/E ratio | 16.95 | 23.72 |
Last price | $66.59 | $170.10 |
Inception | — | — |
Issuer | iShares | iShares |
EEM top holdings
| 2330.TW | Taiwan Semiconductor Manufacturing Co Ltd | 14.37% |
| 005930.KS | Samsung Electronics Co Ltd | 6.11% |
| 000660.KS | SK Hynix Inc | 4.03% |
| 0700.HK | Tencent Holdings Ltd | 3.30% |
| 9988.HK | Alibaba Group Holding Ltd Ordinary Shares | 2.41% |
| 2308.TW | Delta Electronics Inc | 1.13% |
| 2454.TW | MediaTek Inc | 1.05% |
| 00939 | China Construction Bank Corp Class H | 0.93% |
| HDFCBANK.NS | HDFC Bank Ltd | 0.79% |
| RELIANCE.NS | Reliance Industries Ltd | 0.77% |
IBB top holdings
| AMGN | Amgen Inc | 7.37% |
| GILD | Gilead Sciences Inc | 7.32% |
| VRTX | Vertex Pharmaceuticals Inc | 7.21% |
| REGN | Regeneron Pharmaceuticals Inc | 6.55% |
| ALNY | Alnylam Pharmaceuticals Inc | 3.71% |
| ARGX | argenx SE ADR | 3.33% |
| INSM | Insmed Inc | 2.70% |
| BIIB | Biogen Inc | 2.67% |
| NTRA | Natera Inc | 2.40% |
| RVMD | Revolution Medicines Inc Ordinary Shares | 2.27% |
About EEM
EEM (iShares MSCI Emerging Markets ETF) is Liquid emerging-market equities. Managed by iShares, the fund carries $28.1B in assets under management, an expense ratio of 0.72%, a dividend yield of 1.91%. Its largest holding is Taiwan Semiconductor Manufacturing Co Ltd (2330.TW), which represents 14.4% of the portfolio. Real Estate is the fund's largest sector exposure at 1.1%.
About IBB
IBB (iShares Biotechnology ETF) is NASDAQ biotech and pharmaceutical companies. Managed by iShares, the fund carries $7.9B in assets under management, an expense ratio of 0.44%, a dividend yield of 0.23%. Its largest holding is Amgen Inc (AMGN), which represents 7.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.